Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-06

Clinical Trial Update: Dose Response of Epinephrine [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating the dose-response of epinephrine in people with diabetes mellitus with complications. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Diabetes Complications | EARLY_Phase 1 | Status: COMPLETED